Orion Oyj Stock Forecast, Price & News

0.00 (0.00 %)
(As of 06/23/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Average Volume5 shs
Market Capitalization$6.01 billion
P/E Ratio24.20
Dividend Yield2.49%
30 days | 90 days | 365 days | Advanced Chart
Receive ORINY News and Ratings via Email

Sign-up to receive the latest news and ratings for Orion Oyj and its competitors with MarketBeat's FREE daily newsletter.

Orion Oyj logo

About Orion Oyj

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, as well as Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler for the treatment of asthma and chronic obstructive pulmonary disease. The company also offers veterinary drugs; and APIs for generic and proprietary drugs, as well as provides contract manufacturing services. In addition, it markets and sells veterinary drugs manufactured by other international companies. The company has a collaboration with Nanoform to apply Nanoform's CESS technology to new chemical entities. It serves various healthcare service providers and professionals, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. Orion Oyj has partnership with Propeller Health to connect the Easyhaler(R) line of inhalers for asthma and COPD to Propeller's digital medicine platform. Orion Oyj is headquartered in Espoo, Finland.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.71 out of 5 stars

Medical Sector

1321st out of 2,118 stocks

Private Households Industry

215th out of 381 stocks

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Orion Oyj (OTCMKTS:ORINY) Frequently Asked Questions

What stocks does MarketBeat like better than Orion Oyj?

Wall Street analysts have given Orion Oyj a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Orion Oyj wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Orion Oyj's next earnings date?

Orion Oyj is scheduled to release its next quarterly earnings announcement on Friday, July 16th 2021.
View our earnings forecast for Orion Oyj

How were Orion Oyj's earnings last quarter?

Orion Oyj (OTCMKTS:ORINY) posted its earnings results on Tuesday, April, 27th. The company reported $0.25 earnings per share (EPS) for the quarter. The company had revenue of $323.90 million for the quarter. Orion Oyj had a trailing twelve-month return on equity of 30.09% and a net margin of 19.75%.
View Orion Oyj's earnings history

How has Orion Oyj's stock price been impacted by Coronavirus?

Orion Oyj's stock was trading at $20.78 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ORINY shares have increased by 2.5% and is now trading at $21.30.
View which stocks have been most impacted by COVID-19

Is Orion Oyj a good dividend stock?

Orion Oyj pays an annual dividend of $0.53 per share and currently has a dividend yield of 2.49%.
View Orion Oyj's dividend history.

Who are Orion Oyj's key executives?

Orion Oyj's management team includes the following people:
  • Mr. Timo Lappalainen, CEO, Pres & Chairman of the Exec. Management Board (Age 59, Pay $1.64M)
  • Mr. Jari Karlson M.Sc., M.Sc. (Econ.), CFO, Sr. VP of Animal Health & Member of the Exec. Management Board (Age 60)
  • Mr. Olli Huotari, Sr. VP of Corp. Functions, Gen. Counsel, Sec. & Member of Exec. Management Board (Age 55)
  • Ms. Satu Ahomäki, Sr. VP of Commercial Ops, Global Sales & Proprietary Products and Member of the Exe. Mgmt. Board (Age 55)
  • Dr. Liisa Hurme, Sr. VP of Supply Chain & Member of the Exec. Management Board (Age 54)
  • Ms. Virve Laitinen, Sr. VP of Specialty Products & Member of Exec. Management Board (Age 49)
  • Prof. Outi Vaarala M.D., Ph.D., Sr. VP for R&D and Member of Exec. Management Board (Age 59)
  • Mr. Tuukka Hirvonen M.Sc.(Soc.), Investor Relations & Financial Communications Officer
  • Ms. Terhi Ormio, VP of Communications
  • Prof. Heikki Joensuu M.D., Ph.D., R&D Global Head of Therapy Area Oncology

Who are some of Orion Oyj's key competitors?

What is Orion Oyj's stock symbol?

Orion Oyj trades on the OTCMKTS under the ticker symbol "ORINY."

How do I buy shares of Orion Oyj?

Shares of ORINY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Orion Oyj's stock price today?

One share of ORINY stock can currently be purchased for approximately $21.30.

How much money does Orion Oyj make?

Orion Oyj has a market capitalization of $6.01 billion and generates $1.23 billion in revenue each year.

How many employees does Orion Oyj have?

Orion Oyj employs 3,311 workers across the globe.

What is Orion Oyj's official website?

The official website for Orion Oyj is www.orion.fi.

Where are Orion Oyj's headquarters?

Orion Oyj is headquartered at Orionintie 1A, Espoo H9, 02200.

How can I contact Orion Oyj?

Orion Oyj's mailing address is Orionintie 1A, Espoo H9, 02200. The company can be reached via phone at 358 10 4261 or via email at [email protected]

This page was last updated on 6/25/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.